Table 1.
Sham‐PBS (n = 6) | BDL‐NS (n = 7) | BDL‐DHI (n = 7) | |
---|---|---|---|
Serum ALT (U·L−1) | 45.64 ± 2.15 | 131.7 ± 12.67a | 84.28 ± 15.68b |
Serum AST (U·L−1) | 160.88 ± 8.61 | 780.63 ± 63.03a | 509.11 ± 99.75b |
Serum γ‐GT (U·L−1) | 0.38 ± 0.06 | 64.45 ± 4.79a | 38.58 ± 10.82b |
Serum ALP (U·L−1) | 232.92 ± 14.36 | 407.36 ± 37.35a | 277.2 ± 32.34b |
Serum HA (ng·mL−1) | 33.27 ± 6.55 | 611.06 ± 147.64a | 389.77 ± 93.61 |
Serum LN (ng·mL−1) | 61.91 ± 11.81 | 77.15 ± 3.67 | 69.29 ± 5.62 |
Serum PCIII (ng·mL−1) | 15.82 ± 1.44 | 31.62 ± 1.86a | 23.96 ± 1.34b |
The values are expressed as the mean ± SEM (n = 6 in sham group; n = 7 in BDL‐NS/BDL‐DHI group),
P < 0.05; significantly different from sham group,
P < 0.05; significantly different from BDL‐NS group; ANOVA followed by Tukey's test.